Importantly, a range of cancers affect men and women of reproductive age, including tumours carrying gain-of-function mutations in EZH2. Our mouse model provides evidence that loss of maternal PRC2 function in the germline of adult females disrupts H3K27me3 and results in defects in offspring growth. This evidence concerns the gene EZH2 and cancer.